Dr. Eckel Animal Nutrition has entered into a partnership with Evonik, one of the world leaders in specialty chemicals

Evonik plans to launch a first product from the partnership – a phytogenic solution developed by Dr. Eckel – in Europe in the first quarter of 2023.

Phytogenics are plant-based feed ingredients which play an important role in sustainable solutions for livestock farming. Dr. Eckel is one of the most experienced and innovative suppliers in the field of phytogenics. The value-orientated family business is one of the world’s foremost companies in the sector with a specific focus on animal welfare, developing products that make animal nutrition more resource-efficient, climate-friendly and healthy.   

“As a dynamic company with a high pace in product development, we are able to create innovations in a comparatively short period of time,” says Dr. Antje Eckel, founder of Dr. Eckel Animal Nutrition. “With a strong partner like Evonik, we can allow selected products to access a much wider market in a short time. We are therefore very happy that together with Evonik we can open up new target groups and customers.”   

Evonik Gut Health Solutions focus primarily on stabilizing the gut health of animals through probiotics such as Ecobiol®, Fecinor®, and GutCare®. The partnership with Dr. Eckel will allow Evonik to address further animal health issues with selected products that expand Evonik’s portfolio.   

"It often needs complex solutions to maintain health and productivity in the barn without antibiotics," says Gaetano Blanda, head of the Animal Nutrition business line at Evonik. “In combination with our existing Gut Health Solutions, phytogenics will help farmers achieve this goal.”   

About Dr. Eckel 

Dr. Eckel Animal Nutrition: quality, modern animal nutrition made in Germany. The company was set up in 1994 by Dr agr. Antje Eckel. The start-up has developed into an international hidden champion in the field of innovative feed additives for livestock and aquaculture.   

The industry pioneer’s products, which are sold worldwide, combine commercially successful animal nutrition with animal welfare. They make an important contribution to sustainable food production and have received multiple research and industry awards.  

Employees from 20 countries—highly qualified experts in agricultural science, veterinary medicine, microbiology, chemistry and pharmacy—conduct research and work towards making animal nutrition healthier, more successful and more sustainable. More than 10 per cent of the revenue is invested in innovation every year. Numerous prizes for innovation, national and European project funding, and lively dialogue with international research institutes are ample testimony to the reputation that Dr. Eckel has earned through its constant leadership position. Antje Eckel herself has been commended for her entrepreneurial work several times. In 2018, she was appointed to the SME Advisory Board at the Federal Ministry for Economic Affairs and Energy.  

About Evonik 

Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €15 billion and an operating profit (adjusted EBITDA) of €2.38 billion in 2021. Evonik goes far beyond chemistry to create innovative, profitable and sustainable solutions for customers. About 33,000 employees work together for a common purpose: We want to improve life today and tomorrow.  

The focus of the business of the Nutrition & Care division is on health and quality of life. It develops differentiated solutions for active pharmaceutical ingredients, medical devices, nutrition for humans and animals, personal care, cosmetics, and household cleaning. In these resilient end markets, the division generated sales of €3.56 billion in 2021 with about 5,300 employees. 


This press release may include projections based on current assumptions and forecasts made by the management of Dr. Eckel Animal Nutrition GmbH & Co. KG. Various risks—both known and unknown—uncertainties and other factors may cause the actual results, financial situation, development or performance of Dr. Eckel Animal Nutrition GmbH & Co. KG to vary significantly from the estimates provided here. Such factors include those described by Dr. Eckel Animal Nutrition GmbH & Co. KG in published reports. Dr. Eckel Animal Nutrition GmbH & Co. KG shall accept no liability whatsoever for updating such projections and adjusting them to future events or developments.  

Contact information 

Andrea Dietrich 

PR & Communication Manager 

Scroll to Top